Abstract:BACKGROUND AND OBJECTIVE:Due to the synergistic effects of drugs, drug combination is one of the effective approaches for treating complex diseases. However, the identification of drug combinations by dose-response methods is still costly. It is promising to develop supervised learning-based approaches to predict potential drug combinations on a large scale. Nevertheless, these approaches have the inadequate utilization of heterogeneous features, which causes the loss of information useful to classification. Moreover, they have an intrinsic bias, because they assume unknown drug pairs as non-combinations, of which some could be real drug combinations in practice.METHODS:To address above issues, this work first designs a two-layer multiple classifier system (TLMCS) to effectively integrate heterogeneous features involving anatomical therapeutic chemical codes of drugs, drug-drug interactions, drug-target interactions, gene ontology of drug targets, and side effects. To avoid the bias caused by labelling unknown samples as negative, it then utilizes the one-class support vector machines, (which requires no negative instance and only labels approved drug combinations as positive instances), as the member classifiers in TLMCS. Last, both a 10-fold cross validation (10-CV) and a novel prediction are performed to validate the performance of TLMCS.RESULTS:The comparison with three state-of-the-art approaches under 10-CV exhibits the superiority of TLMCS, which achieves the area under the receiver operating characteristic curve = 0.824 and the area under the precision-recall curve = 0.372. Moreover, the experiment under the novel prediction demonstrates its ability, where 9 out of the top-20 predicted combinative drug pairs are validated by checking the published literature. Furthermore, for each of the newly-validated drug combinations, this work analyses the combining mode of the member drugs and investigates their relationship in terms of drug targeting pathways.CONCLUSIONS:The proposed TLMCS provides an effective framework to integrate those heterogeneous features and is trained by only positive samples such that the bias of taking unknown drug pairs as negative samples can be avoided. Furthermore, its results in the novel prediction reveal five types of drug combinations and three types of drug relationships in terms of pathways.

Drug Discrimination Method Based on Near Infrared Reflectance Spectrum and Balance Cascading Sparse Representation Based Classification

[Drug discrimination by near infrared spectroscopy based on summation wavelet extreme learning machine]

CBF-IDS: Addressing Class Imbalance Using CNN-BiLSTM with Focal Loss in Network Intrusion Detection System

On-Site Identification of Counterfeit Drugs Based on Near-Infrared Spectroscopy Siamese-Network Modeling

Application and MATLAB realization of drugs' classification based on the combination of NIRS detection and BP ANN algorithm

Wavelet-Based Classification and Influence Matrix Analysis Method for the Fast Discrimination of Chinese Herbal Medicines According to the Geographical Origins with Near Infrared Spectroscopy

Discrimination of Chinese Patent Medicines Using Near-Infrared Spectroscopy and Principal Component Accumulation Method

Predicting Combinative Drug Pairs Via Multiple Classifier System with Positive Samples Only

Multivariety and multimanufacturer drug identification based on near-infrared spectroscopy and recurrent neural network

Detecting Drug Communities and Predicting Comprehensive Drug–drug Interactions Via Balance Regularized Semi-Nonnegative Matrix Factorization

Deep Learning-Based Imbalanced Data Classification for Drug Discovery

Discrimination of the Specific Gravity of Urine Using Spectrophotometry by the Parallel Connection of Two Modified Feature Selection Methods

FACE DETECTION SYSTEM BASED ON IMBALANCED CLASSIFICATION

Discriminant Analysis of Chinese Patent Medicines Based on Near-Infrared Spectroscopy and Principal Component Discriminant Transformation

[Near-Infrared Spectral Quantitative Analysis by Combining Classification with Local PLS].

[Fast Discrimination of Drugs by Improved Projection Algorithm Based on Raman Spectroscopy]

A Classification Method for Imbalance Data Set Based on Hybrid Strategy

Discrimination of Approved Drugs from Experimental Drugs by Learning Methods

A class-imbalanced hybrid learning strategy based on Raman spectroscopy of serum samples for the diagnosis of hepatitis B, hepatitis A, and thyroid dysfunction

Discrimination of Plant Samples Using Near-Infrared Spectroscopy with A Principal Component Accumulation Method

Design and Application of the Discrimination Filter for Near-Infrared Spectroscopic Analysis